Search Results

Genetown

PlaqueTec recruits first ten patients in BIOPATTERN trial

PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease, announced that it has received the UK’s Medicines and Healthcare products Regulatory Agency approval to continue its BIOPATTERN trial following recruitment of the first ten patients with CAD.

November 29, 2023

·

4 min read

PlaqueTec Announces First Peer-Reviewed Publication for its Liquid Biopsy System (LBS)

PlaqueTec today announced the publication of the first peer-reviewed article demonstrating the feasibility and potential of the PlaqueTec Liquid Biopsy System to detect biomarkers for coronary artery disease.

January 3, 2018

·

5 min read

Business

PlaqueTec Announces the Appointment of Annalisa Jenkins, MBBS, FRCP, as CEO

Dr. Jenkins, most recently CEO of U.S.based Dimension Therapeutics, will lead the 2018 launch of the pioneering biomarker-based PlaqueTec LBS.

November 13, 2017

·

4 min read

Astellas and Universal Cells Ink $124M R&D Pact fo

Business

Cambridge’s PlaqueTec Names Former Dimension Therapeutics CEO as New Leader

The life sciences leader will guide the company through its next growth phase and product launch in 2018.

November 13, 2017

·

4 min read

Business

PlaqueTec Announces The Appointment Of Dr Nick West As CMO

November 18, 2015

·

2 min read

Business

Skye Bioscience Appoints Dr. Annalisa Jenkins to Board of Directors

Skye Bioscience, Inc. is pleased to announce the appointment of Dr. Annalisa Jenkins, MBBS, FRCP, to the Company’s Board of Directors.

March 4, 2024

·

4 min read

Business

PlaqueTec Announces The Appointment Of Dr Tim Brears As CEO

September 24, 2015

·

2 min read

Business

AOBiome Therapeutics Announces the Expansion of its Board of Directors

New appointments integrate broad expertise in clinical development, medicine, finance and business management.

August 6, 2018

·

5 min read

Business

New Scientific Advisory Board adds 70 years of R&D expertise to Turbine’s simulation-first drug discovery mission

Turbine, a simulation-first drug discovery company, announced the formation of its Scientific Advisory Board with the appointments of Dr. Annalisa Jenkins, Dr. Mihriban Tuna, and Dr. Alan Barge.

January 9, 2020

·

7 min read

Business

Dr Annalisa Jenkins and Lord Michael Grade Appointed as Advisors to AKL Research & Development

Appointments bolster team dedicated to bringing osteoarthritis drug to market

December 11, 2018

·

7 min read